Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F X Vollenweider

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 20, 2001
Caveat emptor: editors bewareF X Vollenweider, R T Jones, M J Baggott
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 27, 1998
Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteersF X Vollenweider, A Gamma, M Liechti, et al.
Journal of Clinical Psychopharmacology|February 24, 2001
No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography studyA Gamma, A Buck, T Berthold, et al.
Emergency Medicine Journal : EMJ|April 10, 2010
Effects of a beta-blocker on the cardiovascular response to MDMA (Ecstasy)C M Hysek, F X Vollenweider, M E Liechti
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 11, 1999
Is a single dose of MDMA harmless?F X Vollenweider, A Gamma, M Liechti, et al.
Psychopharmacology|June 15, 1999
Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humansF X Vollenweider, S Remensberger, D Hell, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 25, 2000
Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopramM E Liechti, C Baumann, A Gamma, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 8, 1999
5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]racloprideF X Vollenweider, P Vontobel, D Hell, et al.
Pharmaceutica Acta Helvetiae|June 1, 1997
Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in manF Hasler, D Bourquin, R Brenneisen, et al.
Journal of Psychopharmacology (Oxford, England)|July 19, 2008
Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMAF Hasler, E Studerus, K Lindner, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 20, 2001
Caveat emptor: editors bewareF X Vollenweider, R T Jones, M J Baggott
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 27, 1998
Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteersF X Vollenweider, A Gamma, M Liechti, et al.
Journal of Clinical Psychopharmacology|February 24, 2001
No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography studyA Gamma, A Buck, T Berthold, et al.
Emergency Medicine Journal : EMJ|April 10, 2010
Effects of a beta-blocker on the cardiovascular response to MDMA (Ecstasy)C M Hysek, F X Vollenweider, M E Liechti
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 11, 1999
Is a single dose of MDMA harmless?F X Vollenweider, A Gamma, M Liechti, et al.
Psychopharmacology|June 15, 1999
Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humansF X Vollenweider, S Remensberger, D Hell, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 25, 2000
Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopramM E Liechti, C Baumann, A Gamma, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 8, 1999
5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]racloprideF X Vollenweider, P Vontobel, D Hell, et al.
Pharmaceutica Acta Helvetiae|June 1, 1997
Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in manF Hasler, D Bourquin, R Brenneisen, et al.
Journal of Psychopharmacology (Oxford, England)|July 19, 2008
Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMAF Hasler, E Studerus, K Lindner, et al.
Pageof 4